GGrantIndex
Sort

53,477 grants matching addiction

How the 3D architecture of the brain shapes cancer cell fate decisions

$1,602,000
Mariella Gruber Filbin · Dana-Farber Cancer Inst · DP2 · FY2021 · NS

14/24 The Healthy Brain & Child Development National Consortium

$1,601,908
Gretchen E. Bandoli · University Of California, San Diego · U01 · FY2023 · DA

Clinical Trials Network: New Mexico Node

$1,601,649
University Of New Mexico · U10 · FY2003 · DA

Mass JCOIN II Clinical Research Hub

$1,600,955
Elizabeth A. Evans · University Of Massachusetts Amherst · RM1 · FY2025 · DA

Functional consequences of putative analgesic receptor activation in human DRG neuronal cultures from healthy donors

$1,600,421
Carlos Tristan · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR

Wake Forest Translational Alcohol Research Center (WF-TARC)

$1,600,290
Jeffrey L. Weiner · Wake Forest University Health Sciences · P50 · FY2023 · AA

HEAL Data2Action Modeling and Economic Resource Center

$1,599,903
Bruce R Schackman · Weill Medical Coll Of Cornell Univ · U24 · FY2024 · DA

University of Washington Center of Excellence in Opioid Addiction Research

$1,599,427
Charles Chavkin · University Of Washington · P30 · FY2024 · DA

University of Washington Center of Excellence in Opioid Addiction Research

$1,598,795
Charles Chavkin · University Of Washington · P30 · FY2025 · DA

MRI Resource for Physiologic, Metabolic and Anatomic Biomarkers

$1,598,115
Peter Cm Van Zijl · Hugo W. Moser Res Inst Kennedy Krieger · P41 · FY2021 · EB

Clinical Trials Network: The Texas Node

$1,597,849
Madhukar H Trivedi · Ut Southwestern Medical Center · UG1 · FY2019 · DA

Behavioral Genomics of Alcohol Neuroadaptation

$1,597,360
Tamara J. Phillips · Oregon Health & Science University · P60 · FY2022 · AA

Center the Neurobiological Investigation of Drug Abuse

$1,597,319
Wake Forest University Health Sciences · P50 · FY2004 · DA

CTN: Harvard University Northern New England Node

$1,596,957
Mc Lean Hospital (Belmont, Ma) · U10 · FY2004 · DA

Alcohol Pharmacokinetics and Pharmacodynamics in Humans

$1,596,171
Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2021 · AA

A Cluster RCT to Increase HIV Testing in Substance Use Treatment Programs

$1,595,847
Lisa R Metsch · Columbia University Health Sciences · R01 · FY2016 · DA

Transition to Human Phase 1b Trials: Nonclinical Studies of an Anti-METH mAb

$1,594,873
Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA

Coalition for harm reduction and prevention (CHRP): Developing and testing a novel Hub and Spoke Model to implement prevention and harm reduction in rural clinics

$1,594,805
Lewei Allison Lin · University Of Michigan At Ann Arbor · R61 · FY2024 · DA

Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration

$1,593,318
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2021 · DA

Characterization of neuronal ensembles activated during drug-induced behavior

$1,593,240
Bruce Hope · National Institute On Drug Abuse · ZIA · FY2012 · DA

Development of a5* nAChR positive allosteric modulators for tobacco dependence

$1,593,145
Paul J Kenny · Scripps Research Institute, The · R01 · FY2011 · DA

Advancing a non-addictive, peripherally acting opioid analgesic as a medication strategy to prevent opioid use disorder in patients undergoing treatment for pain

$1,593,126
Virginia J Sanders · Dimerx · UG3 · FY2025 · DA

DRUGS OF ABUSE -- ROLE OF PROTEIN PHOSPHORYLATION

$1,590,306
Paul Greengard · Rockefeller University · P01 · FY2010 · DA

Biological And Biochemical Characterization Of Sigma Receptors

$1,589,813
Tsung Ping Su · National Institute On Drug Abuse · ZIA · FY2025 · DA

Center for the Neurobiology of Addiction Treatment

$1,589,690
Michael A Nader · Wake Forest University Health Sciences · P50 · FY2019 · DA